Initial Therapeutics co-founders (from L-R) Jamie Cate, Brian Paegel and Kevan Shokat
May 1, 2023 07:15 AM EDT
Financing
Startups

'Un­drug­gable is on­ly at a giv­en point in time': Promi­nent Cal­i­for­nia sci­en­tists launch Ini­tial Ther­a­peu­tics with $75M

Lei Lei Wu

News Reporter

Pro­teins are the epit­o­me of or­ga­nized chaos — a jum­ble of mol­e­c­u­lar spi­rals, sheets and links col­laps­ing on top of each oth­er. But they come to­geth­er …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

A service from the Financial Times